Navigation Links
Universal Health Services, Inc. Reports 2007 Third Quarter Earnings
Date:10/29/2007

Consolidated Results of Operations:

KING OF PRUSSIA, Pa., Oct. 29 /PRNewswire-FirstCall/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income was $28.9 million, or $.54 per diluted share, during the third quarter of 2007 as compared to $113.9 million, or $2.00 per diluted share, during the comparable prior year quarter. For the nine months ended September 30, 2007, reported net income was $130.4 million, or $2.43 per diluted share, as compared to $225.3 million, or $3.89 per diluted share, during the comparable nine-month period in the prior year.

As indicated on the attached Schedules of Non-GAAP Supplemental Consolidated Statements of Income Information ("Supplemental Schedules"), our income from continuing operations and net income for the three and nine-month periods ended September 30, 2007 and 2006 include various items such as: (i) hurricane related expenses, net of recoveries, minority interests and income taxes; (ii) prior period effect of the recording or reserving of Texas Medicaid supplemental payments and cost reports settlements, net of income taxes; (iii) reserve for legal judgments, the write-down of the carrying-value of investment in a joint-venture and gain on sale of real property, net of income taxes; (iv) favorable income tax adjustments to reduce reserves due to the expiration of statute of limitations in various tax jurisdictions; (v) prior period effect of a favorable after-tax adjustment to reduce our professional and general liability self-insurance reserves based upon the results of a third-party actuarial analysis, and; (vi) a charge incurred during the third quarter of 2006 to record the aggregate present value of the futu
'/>"/>

SOURCE Universal Health Services, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine news :

1. Demand for universal flu vaccination
2. Universal Early Intervention a Must
3. Dartmouth Professor Makes Case for Ethically Universal Stem Cell Lines
4. Human Trial for Universal Influenza Vaccine Underway
5. Poor health care in Russia maybe causing Decline in its Population
6. Startling Expose – Physicians Often Have No Regular Source Of Health Car
7. Debate Rages over firing of HIV infected health care workers
8. Want a Healthy brew? Have some Tea!
9. Patient’s perception of health status helps in better recover
10. Antioxidants protect health tissue in people undergoing radiation therapy.
11. Sexual abuse affect health for a lifetime

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...., Nov. 27 GSI Group Inc...of precision technology products and semiconductor...f the Company,s shareholders has been scheduled fo...f the meeting will be announced in due course. As...isition notice from Stephen Bershad, a holder of g...
(Date:11/27/2009)...Biotech firm Replikins Ltd. today issued its lates...ata. It shows that the lethality of the virus has...e virus,s current outbreak in the spring of 2009 t...d. 0.1). The H1N1 infectivity count, however, rema...PRWEB) November 27, 2009 -- Biotech firm Replikins...
(Date:11/27/2009)...Nov. 27 The Gymboree Cor...bert, CFO/COO, will present at the NASDAQ OMX 23rd...air Hotel in London, England, on Wednesday, Decemb...a live broadcast of The Gymboree Corporation,s pre...gymboree.com, click on "Our Company" at the bottom...
(Date:11/27/2009)...SEINE, France, Nov. 27 Team Garmin...ng team dedicated to ethical sporting and developi...nced today that it will become Team Garmin-Transit... new sponsor of the team. Transitions Optical is t...r, offering the most advanced photochromic technol...
(Date:11/27/2009)...XenaCare Holdings has announced that it has become...ne of the largest nonprofit organizations dedicate...n. , Delray Beach, FL (Vo...(OTCBB: XCHO), a company specializing in the marke...e products, has announced today that is has become...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4
... has backed down from his earlier stand and has sa...e and not compulsory. // "We are planning to...couple to go for the HIV/AIDS tests before marriag...DS is linked to the tourism." he added that the to...
...erdeen in the UK say in a new study that low mater...sk of asthma in kids//. The study is a continuatio...t low vitamin E in mothers was linked to increased...a, persistent wheeze, wheezing or asthma during th...
... reduce the amount of sugar (glucose) in the blood....// Type 2 diabetes occurs when people canno...properly. Insulin is the essential hormone that he...he disease is mainly confined to people over the a...
...Carolina Wilmington announce the continuation of f... tide brevetoxins and ultimately// yield treatment...Sciences awarded UNCW the five-year $7.53 million ... "Preliminary studies with red tide toxin have ...
...rmed in Wisconsin, the outbreak of the disease is ...e person has succumbed to the disease in the state...ases have needed hospital admission and four of th... places affected are Green Lake counties and Outag...
...s shrink and new infectious agents threaten blood ...t outcomes by implementing// transfusion alternati...s? These questions, and the positive steps that ca...Annual National Meeting in Jersey City, New Jersey...
Other Medicine News:Health News:"Beach to Bedside" Study Focuses on Effects of Inhaled Toxins 2
(Date:11/29/2009)...wire/ -- A large proportion of patients who underg...e unindicated and unnecessary additional image acq...exposure, according to a study presented today at ...North America (RSNA). ,, "It is the responsibil...tion to ensure that the dosage is as low as reason...
(Date:11/29/2009)...Newswire/ -- Royal Philips Electronics ( PHG, AEX:...need by showing its portfolio of products designed...al meeting of the Radiological Society of North Am...ps are several advancements and upgrades focused o...streamlining workflow to expand upon clinical capa...
(Date:11/29/2009)...ewswire/ -- FUJIFILM Medical Systems USA, Inc., th...FFDM) with over 7,000 installations, is pleased to...me in the US. The Aspire HD combines the use of a...generation detector technology and the smallest pi... resolution at a reduced dose for the patient. Th...
Breaking Medicine Technology:Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 2Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4Intralase 26amp 3B 238220 3BBladeless 26amp 3B 238221 3B Lasik Gains Popularity in the Raleigh NC Area 49584 1Intralase 26amp 3B 238220 3BBladeless 26amp 3B 238221 3B Lasik Gains Popularity in the Raleigh NC Area 49584 2U S Army Increases Medical and Dental School Benefits 49582 1U S Army Increases Medical and Dental School Benefits 49582 2U S Army Increases Medical and Dental School Benefits 49582 3BioMed Realty Trust Closes New 2418 Million Secured Loan 49580 1BioMed Realty Trust Closes New 2418 Million Secured Loan 49580 2BioMed Realty Trust Closes New 2418 Million Secured Loan 49580 3
...herapeutic Proteins at Tumor,Site, ARLINGTON HEIG...eons have delivered cancer fighting proteins throu...ith a 79 percent reduction,in tumor volume, accord...onstructive Surgery(R), the official medical journ...PS). This new delivery technique, which has,yet to...
...,AZN) today announced the submission of a suppleme...and Drug Administration (FDA) for SEROQUEL XR(TM),...seek approval for the,treatment of generalized anx...anxiety effect. It is the first time approval has ... in GAD. The submission is based on a robust,clini...
Other Medicine Technology:Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 2AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 5AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 6AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 7AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 8
...er is designed for fast & easy operation. The 5.7 ...for everyone., ,In AUTO mode, the readings are...ned. Multi-Focal lenses are automatically detected...rrectly position the lens. The color touch panel d...
Pro-lll
FF 450plus Fundus Camera
TRC-50FXC
Medicine Products: